The psychostimulant drug, fenethylline (captagon): Health risks, addiction and the global impact of illicit trade
- PMID: 40151181
- PMCID: PMC11946500
- DOI: 10.1016/j.dadr.2025.100323
The psychostimulant drug, fenethylline (captagon): Health risks, addiction and the global impact of illicit trade
Abstract
Fenethylline (street name, captagon) is a synthetic amphetamine-type stimulant that is emerging as a significant public health and security concern, particularly in the Middle East. This systematic review synthesizes original research articles, epidemiological studies, systematic reviews, policy analyses, and case reports to provide a comprehensive analysis of fenethylline's health impacts, addiction potential, and dynamics of illicit trade. Initially developed for therapeutic use, fenethylline illicit production and use have escalated, raising concern about its physiological, psychological, and socio-economic impacts. This stimulant profoundly affects the central nervous system, enhancing wakefulness, concentration, and physical stamina while inducing euphoria. These effects come at the cost of serious adverse health outcomes, particularly with prolonged or heavy use, including cardiovascular complications, neurological damage, and addiction. The dependence-forming nature of captagon contributes to escalating substance use disorders, impacting healthcare systems. Beyond its biomedical implications, fenethylline trafficking has become a global issue, with supply chains deeply intertwined with politically unstable regions where illicit economies thrive. The geopolitical dimensions of captagon's trade amplify its global security threat, influencing international relations and regional stability. This paper underscores the urgent need for systematic data collection and coordinated efforts to regulate illicit fenethylline production and distribution. Strategies such as improved surveillance, public health interventions, and international cooperation are essential to mitigate its escalating risks. Addressing this issue requires a multidisciplinary approach, integrating public health, law enforcement, and policy development to curb its impact on global health and security.
Keywords: Addiction; Global trafficking; Illicit trade; Psychostimulant; Public health; Withdrawal symptoms.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks.Saudi Pharm J. 2024 Nov;32(11):102188. doi: 10.1016/j.jsps.2024.102188. Epub 2024 Oct 22. Saudi Pharm J. 2024. PMID: 39512334 Free PMC article.
-
Qualitative Exploration of the Experiences of People Who Use Captagon and Therapists in Jordan.Subst Use Misuse. 2024;59(5):816-824. doi: 10.1080/10826084.2024.2304012. Epub 2024 Jan 23. Subst Use Misuse. 2024. PMID: 38263603
-
Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):133-40. doi: 10.1111/bcpt.12584. Epub 2016 Apr 8. Basic Clin Pharmacol Toxicol. 2016. PMID: 27004621 Review.
-
The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review.Cureus. 2024 Feb 27;16(2):e55053. doi: 10.7759/cureus.55053. eCollection 2024 Feb. Cureus. 2024. PMID: 38550445 Free PMC article. Review.
-
Captagon: use and trade in the Middle East.Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2548. Epub 2016 Oct 21. Hum Psychopharmacol. 2017. PMID: 27766667 Review.
References
-
- Abazid H. In: Handbook of Substance Misuse and Addictions. Patel V.B., Preedy V.R., editors. Springer International Publishing; Cham: 2022. Drug Abuse in the Middle East; pp. 2629–2648. - DOI
-
- Abu-Hashem A.A., Hakami O., El-Shazly M., El-Nashar H.A.S., Yousif M.N.M. Caffeine and purine derivatives: a comprehensive review on the chemistry, biosynthetic pathways, synthesis-related reactions, biomedical prospectives and clinical applications. Chem. Biodivers. 2024;21 doi: 10.1002/cbdv.202400050. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources